Understanding the epidemiology, natural history, and key pathways involved in prostate cancer.
about
Anticancer activity of green tea polyphenols in prostate glandReduced risk of prostate cancer in childless men as compared to fathers: a systematic review and meta-analysisLong-term survival of cancer patients compared to heart failure and stroke: a systematic review.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publicationsProstate cancer risk profiles of Asian-American men: disentangling the effects of immigration status and race/ethnicityIntegrative network biology: graph prototyping for co-expression cancer networks.Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostateProstate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach.Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cellsTumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.Total cholesterol and cancer risk in a large prospective study in KoreaProstate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer.Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer.OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cellsCadmium induces p53-dependent apoptosis in human prostate epithelial cellsKaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.Advances and future directions in management of prostate cancer.Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.Unraveling Brazilian Indian population prostate good health: clinical, anthropometric and genetic features.Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progressionFatherhood status and risk of prostate cancer: nationwide, population-based case-control study.Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer.Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.Prostate cancer: the need for biomarkers and new therapeutic targets.Anticancer activities of artemisinin and its bioactive derivatives.Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System.In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth.Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts.Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians.The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.TP53INP1 as new therapeutic target in castration-resistant prostate cancer.Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice.The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?
P2860
Q27024257-FF8CA4FC-206D-45CF-BE80-40B0470B504DQ28070364-E1167FB8-E6FC-4976-A9DF-17D4C06A5F9EQ33543986-D0D8298B-2F76-4D35-B172-C474A4AF3D9BQ33605010-1E54C357-C020-453E-B259-EF03D92AD3C6Q33672581-EA531F0F-AC19-46CD-9097-D21A4DCFAD2CQ33733335-7462C00D-BD06-48CF-BD3C-7470C162C501Q33987965-984F0357-45FF-43EE-A453-551BEF28C34FQ34093594-EBC7C0E9-97E6-4D3D-BF63-FAB24EFDB652Q34153891-5E3F3E14-905D-4258-88A1-1CC650EB55A3Q34283636-050B5B4F-317B-41B6-9F27-569D48AFD2F4Q34345432-2DB24232-7862-4543-B508-080683EF892DQ34388229-08F82620-15C2-496B-B1FA-E45041F42603Q34417473-2199E381-F377-407C-8BE0-94CDE085DE58Q34624695-2059015A-C698-447B-BC60-97F89895C55EQ34866268-8202DBF6-CBA4-460E-B147-6C1CD588AB24Q35040473-F168935A-CC0B-448C-A6A6-4E9E5D81D63CQ35056055-7F05EBDF-A3AE-4DB5-8A52-0D6E34B0D795Q35061299-BAD6F40D-2328-4FAB-AE71-CDA058EEEF03Q35127888-7CB14B06-71AE-4778-9CAA-4658ABB71518Q35842539-0471EE57-5E87-451E-8F17-DB3FC6052D71Q35886573-FDA7EF5A-00FC-4733-927D-B1E28B43B761Q36262329-AC9F5536-F6E3-4181-AFD1-121270BB66B8Q36368188-A56CE759-6008-4B63-B680-A4E235D89C9DQ36575833-1F611865-E81C-4C6E-BDEF-3DC021C29366Q36589284-C9263D4F-01ED-4C30-9DB3-77AF3E9FD206Q37073186-A6CF8DED-D166-4F55-81C2-17B8BC38701DQ37295405-0C1B21B1-858A-4D1A-9F25-F47FDED6B2C8Q37417691-B9253DAD-4EC0-48EE-8BC8-0778A405F3EBQ37476043-42BB1417-48E4-4DBB-8CF7-7A0BDBEAEAA8Q37626137-0F193404-6959-42E1-ADCC-F12F31E1EB7BQ38177161-B1B87112-82D4-4D39-B05B-F72D8BF4B8E1Q38766786-4CA363BE-5AEF-4791-9BFF-006ACDC842B4Q38971331-F66870E5-25FD-422C-96A6-A8262C29CC24Q39085996-133E49B1-15A2-4203-B113-47FDF74A3266Q39283679-6DDCD482-414C-43F9-BFB0-01F6AA8D4745Q39301529-25D59952-E0B8-4828-AFA8-53612E91D5E7Q39418724-919BC4BF-C935-4D30-9633-485D0C1115CBQ39564944-D61879CB-6620-46D8-9B47-9D6688B2E1D7Q39775715-36C4AD7E-052F-4282-A8C0-9148435CF6E8Q39852672-18106D19-0744-4E5A-A73C-90AC1C256DCD
P2860
Understanding the epidemiology, natural history, and key pathways involved in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the epidemiology ...... s involved in prostate cancer.
@en
Understanding the epidemiology ...... s involved in prostate cancer.
@nl
type
label
Understanding the epidemiology ...... s involved in prostate cancer.
@en
Understanding the epidemiology ...... s involved in prostate cancer.
@nl
prefLabel
Understanding the epidemiology ...... s involved in prostate cancer.
@en
Understanding the epidemiology ...... s involved in prostate cancer.
@nl
P1433
P1476
Understanding the epidemiology ...... s involved in prostate cancer.
@en
P2093
E David Crawford
P356
10.1016/J.UROLOGY.2009.03.001
P407
P433
P577
2009-05-01T00:00:00Z